Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Cocrystal Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cocrystal Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Cocrystal Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cocrystal Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Cocrystal Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cocrystal Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Cocrystal Pharma Raises USD4 Million in Financing 11
BioZone Pharma Raises USD3.5 Million in Venture Financing 12
BioZone Pharma Raises USD2 Million in Venture Financing 13
BioZone Pharma Raises USD0.8 Million in Venture Financing 14
BioZone Pharma Raises USD0.25 Million in Venture Financing 15
Biozone Pharma Raises USD2.3 Million in Venture Financing 16
Partnerships 17
Cocrystal Pharma Enters into Clinical Trial Agreement with Humanity & Health Research Centre 17
Cocrystal Pharma Enters into Research Agreement with HitGen and InterX 18
Merger 19
RFS Pharma Merges with Cocrystal Pharma 19
BioZone Pharma Completes Merger With Cocrystal Discovery In Reverse Merger Transaction 20
Licensing Agreements 21
Cocrystal Pharma Enters into Licensing Agreement with Duke University and Emory University 21
Cocrystal Pharma Enters into Licensing Agreement with Emory University 23
BioLineRx Enters Into Licensing Agreement With Genoscience Pharma And RFS Pharma For BL-8030 24
Equity Offering 25
Cocrystal Pharma Prices Public Offering of Shares for USD8 Million 25
Cocrystal Pharma Raises USD3 Million in Private Placement of Shares 26
Cocrystal Pharma Raises USD4 Million in Private Placement of Shares 27
Cocrystal Pharma Raises USD5 Million in Private Placement of Shares 28
Debt Offering 29
Cocrystal Pharma Raises USD0.05 Million in Public Offering of Notes Due 2014 29
Cocrystal Pharma Raises USD1 Million in Private Placement of Notes 30
Cocrystal Pharma Inc – Key Competitors 31
Cocrystal Pharma Inc – Key Employees 32
Cocrystal Pharma Inc – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 34
Financial Announcements 34
Aug 09, 2018: Cocrystal Pharma reports 2018 second quarter financial results and provides corporate update 34
May 11, 2018: Cocrystal Pharma Reports 2018 First Quarter Financial Results and Provides Corporate Update 36
Mar 22, 2018: Cocrystal Pharma Reports 2017 Financial Results and Provides Corporate Overview and Business Outlook 38
Nov 08, 2017: Cocrystal Pharma Announces Filing 2017 Third Quarter Financial Statements and Provides Company Update 40
Aug 08, 2017: Cocrystal Pharma Announces Filing 2017 Second Quarter Financial Statements and Provides Company Update 41
Apr 03, 2017: Cocrystal Pharma Reports Financial Results for Fourth Quarter & Year Ended December 31, 2016 and Provides Company Update 42
Corporate Communications 44
Mar 12, 2018: Cocrystal Pharma Announces Uplist to The Nasdaq Capital Market 44
Jun 01, 2017: James J. Martin Appointed as Chief Financial Officer of Cocrystal Pharma 45
Legal and Regulatory 46
Sep 07, 2018: SEC Charges Microcap Fraudsters for Roles in Lucrative Market Manipulation Schemes 46
Clinical Trials 47
May 10, 2018: Cocrystal Pharma to Present at the Fred Hutch and Merck Infectious Disease Summit 47
Apr 03, 2018: Cocrystal Pharma Receives FDA Clearance to Initiate Phase 2a Clinical Study Evaluating CC-31244 for the Treatment of Hepatitis C Virus 48
Aug 15, 2017: Cocrystal Announces Positive Data from the Successful Completion of Phase 1a/1b Trial of the Non-Nucleoside Polymerase Inhibitor CC-31244 for the Treatment of Chronic Hepatitis C Infection 49
Feb 16, 2017: Cocrystal Pharma to Present Clinical Data on its Potent Pan-genotypic NS5B Non-nucleoside Inhibitor CC-31244 at the Asian Pacific Association for the Study of the Liver Annual Meeting 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51
Cocrystal Pharma Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Cocrystal Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cocrystal Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Cocrystal Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cocrystal Pharma Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Cocrystal Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cocrystal Pharma Raises USD4 Million in Financing 11
BioZone Pharma Raises USD3.5 Million in Venture Financing 12
BioZone Pharma Raises USD2 Million in Venture Financing 13
BioZone Pharma Raises USD0.8 Million in Venture Financing 14
BioZone Pharma Raises USD0.25 Million in Venture Financing 15
Biozone Pharma Raises USD2.3 Million in Venture Financing 16
Cocrystal Pharma Enters into Clinical Trial Agreement with Humanity & Health Research Centre 17
Cocrystal Pharma Enters into Research Agreement with HitGen and InterX 18
RFS Pharma Merges with Cocrystal Pharma 19
BioZone Pharma Completes Merger With Cocrystal Discovery In Reverse Merger Transaction 20
Cocrystal Pharma Enters into Licensing Agreement with Duke University and Emory University 21
Cocrystal Pharma Enters into Licensing Agreement with Emory University 23
BioLineRx Enters Into Licensing Agreement With Genoscience Pharma And RFS Pharma For BL-8030 24
Cocrystal Pharma Prices Public Offering of Shares for USD8 Million 25
Cocrystal Pharma Raises USD3 Million in Private Placement of Shares 26
Cocrystal Pharma Raises USD4 Million in Private Placement of Shares 27
Cocrystal Pharma Raises USD5 Million in Private Placement of Shares 28
Cocrystal Pharma Raises USD0.05 Million in Public Offering of Notes Due 2014 29
Cocrystal Pharma Raises USD1 Million in Private Placement of Notes 30
Cocrystal Pharma Inc, Key Competitors 31
Cocrystal Pharma Inc, Key Employees 32
Cocrystal Pharma Inc, Other Locations 33
Cocrystal Pharma Inc, Subsidiaries 33
List of Figures
Cocrystal Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Cocrystal Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Cocrystal Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Cocrystal Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Cocrystal Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cocrystal Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Cocrystal Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cocrystal Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
【免責事項】
http://www.globalresearch.jp/disclaimer